Collegium Pharmaceutical(COLL)
$24.81+0.34 (+1.39%)
COLL
Collegium Pharmaceutical financials statements
$24.81
At close:+0.34 (+1.39%)
Want to see COLL full AI Analyst Report?
Collegium Pharmaceutical (COLL) Income Statement
511 Followers
Collegium Pharmaceutical Income Statement
Last quarter (Q3 2026), Collegium Pharmaceutical's total revenue was $216.34M, an increase of 3.33% from the same quarter last year. In Q3, Collegium Pharmaceutical's net income was $21.76M. See Collegium Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 780.57M | $ 631.45M | $ 566.77M | $ 463.93M | $ 276.87M | |
| $ 463.26M | $ 377.34M | $ 326.17M | $ 209.49M | $ 150.62M | |
| $ 276.17M | $ 207.45M | $ 159.21M | $ 176.17M | $ 132.99M | |
| Depreciation and Amortization | $ 226.07M | $ 169.16M | $ 149.26M | $ 138.94M | $ 68.92M |
| $ 401.00M | $ 341.70M | $ 308.33M | $ 173.31M | $ 86.56M | |
| $ 187.08M | $ 169.90M | $ 166.96M | $ 33.32M | $ 17.63M | |
| $ -94.47M | $ -71.33M | $ -91.23M | $ -62.17M | $ -21.00M | |
| $ 92.62M | $ 98.57M | $ 75.73M | $ -28.85M | $ -3.37M | |
| $ 62.87M | $ 69.19M | $ 48.16M | $ -25.00M | $ 71.52M | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.98 | $ 2.14 | $ 1.60 | $ -0.74 | $ 2.05 |
| Diluted EPS | $ 1.73 | $ 1.86 | $ 1.29 | $ -0.74 | $ 1.86 |
| Weighted Average Shares Outstanding | 31.71M | 32.27M | 33.74M | 33.83M | 34.94M |
| Weighted Average Shares Outstanding (Diluted) | 39.70M | 40.42M | 41.79M | 33.83M | 41.05M |
Currency in USD
